Company Encyclopedia
View More
name
Zeon Corporation
4205.JP
News
View More

Kaneka Acquires Zeon’s Gastrointestinal and Cardiovascular Medical Device Businesses

Kaneka Corporation has agreed to acquire Zeon Corporation's medical device businesses in the gastrointestinal and cardiovascular sectors, operated by Zeon Medical Inc. and River Xemex Co., Ltd. This acquisition will position Kaneka as the third-largest player in the domestic gastrointestinal market, particularly in endoscopic treatment devices. The agreement, signed on November 12, 2025, aims to enhance Kaneka's product portfolio and improve patient quality of life.

Reuters·
4118
0.00%
4205
0.00%
Reuters·
4118
0.00%
4205
0.00%

We Think That There Are Some Issues For Zeon (TSE:4205) Beyond Its Promising Earnings

Zeon Corporation (TSE:4205) reported strong earnings, but the stock remained stagnant due to investor concerns over sustainability, particularly from a JP¥15b gain attributed to unusual items. Analysts suggest that these unusual items may distort the true profitability of the company. Despite a 21% annual growth in EPS over the last three years, potential investors should be cautious of the underlying risks, as there are two warning signs identified for Zeon.

Simplywall·
4205
0.00%
Simplywall·
4205
0.00%

Zeon Corporation Q2 Net Income Doubles as Net Sales Hold Steady

Zeon Corporation reported Q2 FY2025 consolidated net sales of ¥103.4 billion, unchanged from the previous quarter. Net income surged 97% to ¥14.8 billion, attributed to gains from investment securities. The Specialty Materials Business saw a 13% increase in net sales to ¥33.0 billion, despite a 41% drop in operating income. The Elastomer Business experienced a decline in net sales to ¥54.5 billion and operating income fell to ¥2.3 billion. The company also began consolidating Zeon Korea Co., Ltd. and started a new cyclo olefin polymer production plant.

Reuters·
4205
0.00%
Reuters·
4205
0.00%

Can Mixed Fundamentals Have A Negative Impact on Zeon Corporation (TSE:4205) Current Share Price Momentum?

Zeon Corporation (TSE:4205) has seen a 20% increase in stock price over the past three months, but its fundamentals raise concerns about financial health. The company's return on equity (ROE) stands at 7.2%, slightly above the industry average of 6.8%, yet it has experienced flat net income growth over five years. Despite a moderate payout ratio of 41%, the lack of earnings growth suggests potential business decline. Analysts predict future earnings growth, despite past performance, indicating mixed sentiments about the company's prospects.

Simplywall·
4205
0.00%
Simplywall·
4205
0.00%

Zeon's (TSE:4205) Shareholders Will Receive A Bigger Dividend Than Last Year

Zeon Corporation (TSE:4205) will increase its dividend to ¥36.00 on December 3rd, raising the yield to 4.4%. Despite a solid track record of dividend growth, concerns remain about the sustainability of payments due to a lack of free cash flow. Projected EPS growth of 6.5% next year suggests a payout ratio of 59%, which is sustainable. However, the company is not considered a top-tier income stock, and investors should be cautious, considering other factors before investing.

Simplywall·
4205
0.00%
Simplywall·
4205
0.00%